NCT05641623View on ClinicalTrials.gov

OSU6162 as add-on in SSRI/SNRI-resistant Depression

PHASE2RecruitingINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

April 21, 2022

Primary Completion Date

May 31, 2026

Study Completion Date

August 31, 2026

Conditions
DepressionDepressive Disorder, Treatment-ResistantDepressive DisorderDepressive EpisodeRecurrent Depressive DisorderRecurrent Depression
Interventions
DRUG

OSU6162

OSU6162

DRUG

Placebo

Placebo

Trial Locations (4)

11321

NOT_YET_RECRUITING

North Stockholm psychiatry Stockholm region, Stockholm

75185

NOT_YET_RECRUITING

Uppsala University Hospital Department of neuroscience, Uppsala

222 40

RECRUITING

Skåne University Hospital Psychiatry Lund, Lund

Unknown

RECRUITING

Sahlgrenska University Hospital, Gothenburg

All Listed Sponsors
collaborator

Arvid Carlsson Research AB

INDUSTRY

lead

Göteborg University

OTHER